Medicare Enrolled
Dr. Nicholas Fitzsimons, MD
Urology Physician · Charlotte, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Fitzsimons from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Fitzsimons?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Fitzsimons
Dr. Nicholas Fitzsimons is an urology physician in Charlotte, NC, with 18 years of NPI registration. Based on federal Medicare data, Dr. Fitzsimons performed 2,079 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Fitzsimons received a total of $14,118 from 58 pharmaceutical and/or device companies across 352 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Fitzsimons is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 37% volume in NC
$14,118 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗2,079
Medicare services
Top 37% in NC for urology physician
Not available
Unique patients (not deduplicated)
$75
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
451 | $83 | $158 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
301 | $3 | $15 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
282 | $58 | $110 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
221 | $2 | $15 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
133 | $167 | $585 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
78 | $115 | $263 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
52 | $4 | $16 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 52 | $133 | $786 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
49 | $76 | $550 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
48 | $8 | $45 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
41 | $105 | $295 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
37 | $19 | $264 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
36 | $77 | $185 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
35 | $197 | $798 |
| Injection, garamycin, gentamicin, up to 80 mg | 34 | $2 | $7 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
31 | $316 | $1,880 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
28 | $245 | $826 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
28 | $177 | $626 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
26 | $88 | $1,454 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
22 | $117 | $231 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
20 | $101 | $228 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
18 | $265 | $677 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
17 | $20 | $87 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
15 | $147 | $801 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
13 | $175 | $615 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $559 | $2,215 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
4.1% high complexity
14.5% medium
81.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$14,118
Total received (2018-2024)
Avg $2,017/year across 7 years
Top 11% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
58
Companies
352
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,456
2023
$1,905
2022
$1,334
2021
$1,201
2020
$629
2019
$512
2018
$7,080
Payments by company (2024)
UROGEN PHARMA, INC.
$193
Dendreon Pharmaceuticals LLC
$183
Myriad Genetic Laboratories, Inc.
$121
ABBVIE INC.
$99
Bayer Healthcare Pharmaceuticals Inc.
$90
Astellas Pharma US Inc
$86
PFIZER INC.
$85
Ferring Pharmaceuticals Inc.
$66
Janssen Biotech, Inc.
$66
Blue Earth Diagnostics Limited
$63
Novartis Pharmaceuticals Corporation
$61
Sumitomo Pharma America, Inc.
$55
Ethicon US, LLC
$50
BIOPROTECT MEDICAL, INC.
$40
Smith+Nephew, Inc.
$40
Antares Pharma, Inc.
$31
Merck Sharp & Dohme LLC
$27
Kerecis Limited
$26
PROCEPT BioRobotics Corporation
$23
Teleflex LLC
$22
PROGENICS PHARMACEUTICALS, INC.
$16
Endo USA, Inc.
$14
Top 3 companies account for 34.1% of 2024 payments
All-time payments by company (2018-2024) ›
BOSTON SCIENTIFIC CORPORATION
$6,215
Astellas Pharma US Inc
$930
Antares Pharma, Inc.
$703
Janssen Biotech, Inc.
$477
Sumitomo Pharma America, Inc.
$410
Dendreon Pharmaceuticals LLC
$307
Bayer Healthcare Pharmaceuticals Inc.
$256
Boston Scientific Corporation
$255
Endo Pharmaceuticals Inc.
$252
ABBVIE INC.
$246
Laborie Medical Technologies Corp.
$219
Myovant Sciences Inc.
$213
UROGEN PHARMA, INC.
$211
PFIZER INC.
$209
PROCEPT BioRobotics Corporation
$177
Axonics, Inc.
$175
Myriad Genetic Laboratories, Inc.
$168
COLOPLAST CORP
$141
Medtronic, Inc.
$141
Avadel Specialty Pharmaceuticals, LLC
$131
Clarus Therapeutics Inc.
$128
Zyla Life Sciences
$123
Blue Earth Diagnostics Limited
$120
Zyla Life Sciences, Inc.
$119
Janssen Scientific Affairs, LLC
$106
UroGen Pharma, Inc.
$97
Merck Sharp & Dohme LLC
$90
AbbVie, Inc.
$90
Travere Therapeutics, Inc.
$87
AbbVie Inc.
$83
TOLMAR Pharmaceuticals, Inc.
$80
Supernus Pharmaceuticals, Inc.
$77
Ethicon US, LLC
$77
ACCORD HEALTHCARE, INC.
$73
Photocure Inc
$73
Smith+Nephew, Inc.
$72
Teleflex LLC
$71
Ferring Pharmaceuticals Inc.
$66
Kerecis Limited
$66
Coloplast Corp
$65
UROVANT SCIENCES INC
$62
Novartis Pharmaceuticals Corporation
$61
Mission Pharmacal Company
$54
Allergan, Inc.
$47
BIOPROTECT MEDICAL, INC.
$40
Aytu BioScience, Inc
$36
NeoTract Inc.
$30
Retrophin, Inc.
$26
Acerus Pharmaceuticals Corporation
$26
Progenics Pharmaceuticals, Inc.
$20
Olympus America Inc.
$20
Rochester Medical Corporation
$17
PROGENICS PHARMACEUTICALS, INC.
$16
Aytu Bioscience, Inc
$15
Endo USA, Inc.
$14
Verity Pharmaceuticals Inc.
$12
CONMED Corporation
$11
NxThera, Inc.
$10
Top 3 companies account for 55.6% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ADVANCE · AMS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · AirSeal · Androgel · Axonics · Axonics r-SNM System · Axumin · BIOPROTECT BALLOON IMPLANT SYSTEM · BOTOX · CAMCEVI · CYSVIEW · Cysview · ELIGARD · ERLEADA · ETHICON · Erleada · GEMTESA · GENERAL BPH · GENERAL BPH · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · Kerecis Omega3 SurgiClose · LITHOVUE · LUPRON DEPOT · LithoVue · Lupron Depot · MYRBETRIQ · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PERCUFLEX · PLUVICTO · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · Rezum · SPACEOAR VUE · SPEEDICATH · SPRIX · STRAVIX · SpeediCath · THERAPIES · TITAN · TRIA · Thiola · Titan · Trelstar · UROLIFT · Uribel · UroLift · UroLift System · Urocit-K · VESICARE · VISTASEAL · Virtue · XIAFLEX · XTANDI · XYOSTED · Xtandi · ZYTIGA · iTIND System
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Urology physicians in nearby ZIP areas
73
County median income
$83,765
Nearest hospital to ZIP centroid (approximate)
ATRIUM HEALTH PINEVILLE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Fitzsimons is a clinical cardiology specialist, with moderate Medicare volume, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Fitzsimons experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Fitzsimons performed 451 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Fitzsimons receive payments from pharmaceutical companies?
Yes. Dr. Fitzsimons received a total of $14,118 from 58 companies across 352 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Fitzsimons's costs compare to other urology physicians in Charlotte?
Dr. Fitzsimons's average Medicare payment per service is $75. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Fitzsimons) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Charlotte
Browse urology physicians in Charlotte ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
BOSTON SCIENTIFIC CORPORATION Payments to Doctors
See all physicians who received payments from BOSTON SCIENTIFIC CORPORATION.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Antares Pharma, Inc. Payments to Doctors
See all physicians who received payments from Antares Pharma, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology